To read more about the items below, click the link above for a PDF of the newsletter.
WLF NEW FILINGS
- WLF asks the Seventh Circuit to reverse judgments imposing injury- and causation-free tort liability. (Burton v. Armstrong Containers Inc.)
- WLF urges the Delaware Supreme Court not to use the implied covenant of good faith and fair dealing to rewrite contracts. (Glaxo Group Ltd. v. DRIT LP)
- WLF supports a citizen petition that calls on the FDA to stop suppressing truthful scientific speech by clinical laboratories. (In re Access to Pharmacogenomics Information)
WLF CASES DECIDED
- The Ninth Circuit holds that a pharmaceutical trade group lacks standing to seek to enjoin a controversial new California law that imposes liability on drug makers for settling patent litigation. (Ass’n for Accessible Medicine v. Becerra)
- The Supreme Court of Pennsylvania affirms a lower court decision holding that trial courts need not act as “gatekeepers” to ensure the reliability of expert evidence. (Walsh v. BASF Corp.)
- The First Circuit decides that local Amazon delivery drivers cannot be contractually compelled to arbitrate disputes under the Federal Arbitration Act. (Waithaka v. Amazon.com)
- The Supreme Court grants review of a Ninth Circuit ruling that misreads an FTC Act remedy provision. (AMG Capital Management, LLC v. FTC)
- The Supreme Court agrees to review a Ninth Circuit decision that would allow activists to seek to impose liability on U.S. companies for allegedly aiding and abetting human rights violations overseas. (Nestlé USA, Inc. v. Doe)